Skip to main content

Table 4 Magnitude of HCV antibody prevalence among different study population in different regions of Ethiopia from 1988 to 2014

From: Hepatitis viruses in Ethiopia: a systematic review and meta-analysis

Study group Sampling year Study area Study population Anti-HCV Ab frequency (%) References
Community based 1993 A.Ababa & its outskirts 1580 32 (2.0) [56]
1994 A.Ababa 2663 29 (0.8) [55]
2002 Kemissie & Omo 5248 68 (1.3) [28]
Blood donors 1995 A.Ababa 500 7 (1.4) [49]
2003 North Ethiopia 600 10 (1.7) [57]
2004 Gondar 600 35 (5.8) [9]
2006 Bahirdar 324 43 (13.3) [8]
2007 Gondar 6361 35 (0.7) [17]
2008 Bahir Dar 2384 15 (0.6) [13]
2010 Jimma 6063 12 (0.2) [15]
Symptomatic liver disease patients 1988 North Ethiopia 139 20 (14.0) [47]
1992 A.Ababa 110 21 (19.0) [48]
1995 A.Ababa 238 90 (37.8) [49]
2011 A. Ababa 120 27 (22.5) [44]
2011 Gondar 2684 322 (12.0) [50]
2013 Bale Robe 220 6 (2.7) [51]
HIV infected individuals 1994 A. Ababa 165 8(4.8) [55]
2006 A. Ababa 734 50 (6.8) [66]
2008 Hawassa 400 42(10.5) [11]
2011 A. Ababa 500 18 (3.6) [53]
2011 Mekele 174 16(9.2) [12]
2012 D/ Tabour 395 5(1.3) [67]
2013 A.Ababa 387 25(6.5) [68]
2013 Gondar 400 22(5.5) [64]
2013 Bahirdar 269 59(21.9)a [100]
2014 Bahirdar 253 14(5.5) [69]
Othersb 2006 Gondar 480 6 (1.3) [39]
2006 A. Ababa 1220 21 (1.7) [66]
2008 Hawassa 400 24(6.0) [11]
2010 Jimma 304 30 (9.9) [58]
2010 Jimma 300 10 (3.3) [58]
2010 Gamo HP 556 1 (0.2) [33]
2011 Gondar 200 2 (1.0) [32]
2011 Mekele 126 2 (1.6) [12]
2012 D/ Markos 423 6 (1.4) [10]
  1. aReported as 18.9% in the original work, but the 3.0% anti-HCV antibody reported as co-infected with HBsAg was summed up and became 21.9%
  2. bIncludes antenatal care attendants, HIV voluntary counselling and testing (VCT) clients (HIV negative), VCT clients, diabetic patients, non-diabetic patients (controls for diabetic patients), out and inpatient department clients, healthcare workers and medical waste handlers, and VCT clients
\